Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa

CT Doing business as Fundacio Irsi Caixa

UEI
ZBHLKRKAUYK3
CAGE
718DB
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Other Not For Profit Organization
  • Foundation
Entity structure
Other
SAM.gov registration date
Website
irsicaixa.es
Founded
1995
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Consequences of acute HIV infection on the EBV-specific immunity R01DE018925 National Institutes of Health $1,009,105

Grant subawards

Prime recipient Prime award Amount Awarded
University Of California, Davis Statement of work The work at Irsicaixa will seek to identify individuals with accelerated neutralization activity to HIV, and to define the ENV sequences of… P01AI181044 $511,076
University Of California, Davis Statement of work The work at Irsicaixa will seek to identify individuals with accelerated neutralization activity to HIV, and to define the ENV sequences of… P01AI181044 $385,744
Emory University Multi-OMICS identification and validation of mechanisms triggered by Immune interv P01AI178376 $32,875
University Of California, Davis Investigator at IrsiCaixa will perform the following studies for this P01:􀀃 Dr. Brander from IrsiCaixa is a specialist in T-cell responses to HIV who… P01AI178375 $91,460
Scripps Research Institute This award has been revised to reflect Year 4 funding. Year 04 Period of Performance is 05/01/2024-04/30/2025 UM1AI164561 $76,409

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Fundacio Privada Institut De Recerca De La Sida-Caixa, doing business as Fundacio Irsi Caixa, is a leading research center focused on finding solutions and facilitating progress towards curing and eradicating HIV/AIDS. They also conduct research on the immune system.

Through subawards from federal grants, Fundacio Irsi Caixa has provided expertise, biological samples, data analysis, and research services related to T-cell immunity and HIV rebound kinetics after antiretroviral therapy interruption. Specific activities include TCR sequencing of antigen specific T cells, transcriptomics analyses, T cell avidity determinations, and metabolic studies of vaccine-specific T cells. Fundacio Irsi Caixa has partnered with the University of California, Davis as a subawardee on NIH grants to provide these research services.

Quick answers

Is Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa registered in SAM.gov?

Yes. Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa's SAM.gov registration is active through October 7, 2027.

What is Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa's CAGE code?

Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa's CAGE code is 718DB, and its Unique Entity ID (UEI) is ZBHLKRKAUYK3.

What is Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa's most recent federal award?

Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa's most recent federal grant award is Consequences of acute HIV infection on the EBV-specific immunity (R01DE018925), from National Institutes of Health, on August 3, 2007.

On GovTribe

See Fundacio Privada Institut De Recerca Sobre Immunopatologies-Caixa Irsicaixa's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe